Over the latest trailing 12-month period, total return cagr is -90.01%. The comparable SPY value is +16.94%. Year-to-date total return is -83.23%. Total return includes price appreciation and reinvested dividends.
Growth of $10,000 in MEDS
$0
(0.0x return)
Invested on Mar 3, 2009
Growth of $10,000 in SPY (S&P 500)
$154,650
(15.5x return)
Invested on Mar 3, 2009
This chart illustrates the cumulative performance of a hypothetical $10,000 investment. It assumes that all dividends paid by both the stock and SPY are reinvested in additional shares on the payment date, showing the true long-term compounding impact of distributions.
YTD Total Return
-83.2%
1-Year Total Return
-90.1%
Current Dividend Yield
N/A
Compound Annual Growth Rate (CAGR) is shown below. The difference between price CAGR and total return CAGR is the compound contribution of dividends reinvested.
| Holding Period | Price CAGR | Total Return CAGR | Dividend Addition |
|---|---|---|---|
| 1 Year | (90.0%) | (90.0%) | N/A |
| 3 Years | (20.1%) | (20.1%) | +0.0% |
| 5 Years | (45.9%) | (45.9%) | N/A |
| 10 Years | (25.4%) | (25.4%) | N/A |
| 15 Years | (22.7%) | (22.7%) | N/A |
| 20 Years |
| N/A |
| N/A |
| N/A |
